FIBA company, Aeye Health, receives FDA clearance
The Tel Aviv-based healthtech firm AEYE Health announced on Tuesday it has received clearance from the U.S. Food & Drug Administration to market its diagnostic screening system for diabetic retinopathy, a complication of diabetes caused by high blood sugar levels that can damage the retina and cause blindness if left undiagnosed. Instead of needing an annual appointment with an ophthalmologist for screening, AEYE patients will be able to receive initial screening from their primary care physician or at other healthcare facilities including retail pharmacies. Only patients for which the AI system detects potential disease need to be referred to a specialist. That clearance could be a game-changer for the millions of people who are at high risk of diabetic retinopathy (a condition that remains the top cause of blindness in the working-age population).Read the full story: https://www.fastcompany.com/90811773/aeye-health-gets-fda-clearance-to-use-ai-to-screen-diabetics-in-hopes-of-preventing-blindness
Latest News
-
Building Bridges in Uncertainty
November 13, 2023 3:53 pm
-
Tampa's tech scene connection to Israel unaffected by Israel-Hamas war, businesses owners say
November 3, 2023 2:01 pm
-
We have witnessed Hamas’ medieval carnage
October 25, 2023 4:28 pm
-
The Florida-Israel connection: How the state cultivates its Jewish ties
October 20, 2023 4:21 pm
-
Israel business owners with ties to Tampa react to war between Israel and Hamas
October 20, 2023 4:19 pm